Q15418 (KS6A1_HUMAN) Homo sapiens (Human)
Ribosomal protein S6 kinase alpha-1 UniProtKBInterProSTRINGInteractive Modelling
735 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4);
3 identical sequences: Pan troglodytes: K7CK76, A0A6D2XCF0; Gorilla gorilla gorilla: G3SI99
It is possible new templates exist for this target since these models were created.
Available Structures
23 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Heterodimeric structure of ERK2 and RSK1 |
Heteromer P28482; | 2×ANP; 3×SO4; 2×NA; | ||||
| Assess | ||||||
| S100B-RSK1 crystal structure A |
Heteromer P04271; | 4×CA; | ||||
| Assess | ||||||
| S100B-RSK1 crystal structure B |
Heteromer P04271; | 4×CA; 1×CL; | ||||
| Assess | ||||||
| S100B-RSK1 crystal structure A |
Heteromer P04271; | 4×CA; | ||||
| Assess | ||||||
| S100B-RSK1 crystal structure C |
Heteromer P04271; | 4×CA; | ||||
| Assess | ||||||
| Crystal structure of human ERK2 complexed with a MAPK docking peptide |
Heteromer P28482; | 1×ANP; | ||||
| Assess | ||||||
| Crystal structure of human ERK2 complexed with a MAPK docking peptide |
Heteromer P28482; | 1×ANP; | ||||
| Assess | ||||||
| Phospho-ERK2 bound to bivalent inhibitor SBP2 |
Heteromer P28482; | 3×GOL; 1×FRZ; 1×90A; | ||||
| Assess | ||||||
| Phospho-ERK2 bound to bivalent inhibitor SBP3 |
Heteromer P28482; | 5×GOL; 1×FRZ; 1×AKS; | ||||
| Assess | ||||||
| The PDZ domain of SNTG1 complexed with the phosphomimetic mutant PDZ-binding motif of RSK1 |
Heteromer P07355; Q9NSN8; | 5×CA; 3×GOL; | ||||
| Assess | ||||||
| MAGI-1 complexed with a pRSK1 peptide |
Heteromer P07355; Q96QZ7; | 3×GOL; 5×CA; | ||||
| Assess | ||||||
| MAGI-1 complexed with a synthetic pRSK1 peptide |
Heteromer P07355; Q96QZ7; | 3×GOL; 6×CA; | ||||
| Assess | ||||||
| The PDZ domain of SYNJ2BP complexed with the phosphorylated PDZ-binding motif of RSK1 |
Heteromer P07355; P57105; | 4×CA; 2×GOL; | ||||
| Assess | ||||||
| MAGI1_2 complexed with a phosphomimetic RSK1 peptide |
Heteromer P07355; Q96QZ7; | 2×CIT; 1×GOL; 6×CA; | ||||
| Assess | ||||||
| The PDZ domain of SNTG2 complexed with the phosphorylated PDZ-binding motif of RSK1 |
Heteromer P07355; Q9NY99; | 5×CA; 1×GOL; | ||||
| Assess | ||||||
| MAGI-1 complexed with a RSK1 peptide |
Heteromer P07355; Q96QZ7; | 3×GOL; 4×CA; | ||||
| Assess | ||||||
| Crystal Structure of the Human Ribosomal protein S6 kinase | homo-2-mer | 3×NA; 1×CL; 2×PEG; | ||||
| Assess | ||||||
| The Crystal Structure of RSK1 from Biortus. | monomer | 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of human RSK1 C-terminal kinase domain | monomer | 1×NA; | ||||
| Assess | ||||||
| Crystal Structure of the N-terminal Kinase Domain of Human RSK1 bound to Staurosporine | monomer | 1×STU; | ||||
| Assess | ||||||
| Crystal structure of the N-terminal kinase domain of human RSK-1 bound to AMP-PCP | monomer | 1×MG; 1×ACP; | ||||
| Assess | ||||||
| Crystal Structure of the N-terminal Kinase Domain of Human RSK1 bound to Purvalnol A | monomer | 1×P01; | ||||
| Assess | ||||||
| The Crystal Structure of N-terminal kinase domain of human RSK-1 from Biortus. | monomer | 1×ANP; 3×EDO; | ||||
| Assess | ||||||
5 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6g76.1.A | monomer | 0.77 | 1×ANP; | 86.42 | ||
| Assess | ||||||
| 4nif.1.A | monomer | 0.77 | 100.00 | |||
| Assess | ||||||
| 7n91.2.A | monomer | 0.71 | 53.87 | |||
| Assess | ||||||
| 8ewy.1.B | monomer | 0.55 | 20.60 | |||
| Assess | ||||||
| 7t6f.1.A | monomer | 0.55 | 20.60 | |||
| Assess | ||||||
14 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 4nif.1.A | monomer | 0.77 | 100.00 | ||
| Assess | ||||||
| Isoform 2 | 6g76.1.A | monomer | 0.77 | 1×ANP; | 86.42 | |
| Assess | ||||||
| Isoform 2 | 7n91.2.A | monomer | 0.71 | 53.87 | ||
| Assess | ||||||
| Isoform 2 | 8ewy.1.B | monomer | 0.54 | 20.79 | ||
| Assess | ||||||
| Isoform 2 | 7t6f.1.A | monomer | 0.54 | 20.79 | ||
| Assess | ||||||
| Isoform 3 | 4nif.1.A | monomer | 0.77 | 100.00 | ||
| Assess | ||||||
| Isoform 3 | 7n91.2.A | monomer | 0.69 | 53.38 | ||
| Assess | ||||||
| Isoform 3 | 7t6f.1.A | monomer | 0.54 | 22.13 | ||
| Assess | ||||||
| Isoform 3 | 8ewy.1.B | monomer | 0.54 | 22.13 | ||
| Assess | ||||||
| Isoform 4 | 4nif.1.A | monomer | 0.77 | 100.00 | ||
| Assess | ||||||
| Isoform 4 | 6g76.1.A | monomer | 0.77 | 1×ANP; | 86.42 | |
| Assess | ||||||
| Isoform 4 | 7n91.2.A | monomer | 0.71 | 53.87 | ||
| Assess | ||||||
| Isoform 4 | 8ewy.1.B | monomer | 0.55 | 20.79 | ||
| Assess | ||||||
| Isoform 4 | 7t6f.1.A | monomer | 0.53 | 20.79 | ||
| Assess | ||||||